Pediatric Ocular Nanomedicines: Challenges and Opportunities
The eye is a highly complex, yet readily accessible organ within the human body. As such, the eye is an appealing candidate target for a vast array of drug therapies. Despite advances in ocular drug therapy research, the focus on pediatric ocular drug delivery continues to be highly underrepresented due to the limited number of degenerative ocular diseases with childhood onset. In this review, we explore more deeply the reasons underlying the disparity between ocular therapies available for children and for adults by highlighting diseases that most commonly afflict children (with focus on the anterior eye) and existing prognoses, recent developments in ocular drug delivery systems and nanomedicines for children, and barriers to use for pediatric patients
N. D. Sheybani and H. Yang, "Pediatric Ocular Nanomedicines: Challenges and Opportunities," Chinese Chemical Letters, vol. 28, no. 9, pp. 1817-1821, Elsevier B.V., Sep 2017.
The definitive version is available at https://doi.org/10.1016/j.cclet.2017.07.022
Chemical and Biochemical Engineering
Keywords and Phrases
Compliance; Drug administration; Nanomedicine; Ocular drug delivery; Pediatric
International Standard Serial Number (ISSN)
Article - Journal
© 2017 The Authors, All rights reserved.
01 Sep 2017